APPEARANCE OF PHYSICAL-DEPENDENCE AND ANALGESIC ACTIVITY OF 2-(5H-[1]-BENZOPYRANO[2,3-B]PYRIDIN-7-YL)PROPIONIC ACID (Y-8004) BY REPEATED ADMINISTRATION

被引:2
|
作者
MARUYAMA, Y [1 ]
ANAMI, K [1 ]
IMAYOSHI, T [1 ]
IMAMURA, H [1 ]
机构
[1] YOSHITOMI PHARMACEUT IND LTD, RES LABS, FUKUOKA 871, JAPAN
关键词
D O I
10.1248/yakushi1947.97.4_343
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:343 / 349
页数:7
相关论文
共 44 条
  • [41] Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yObenzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor Related Orphan Receptor C2 Inverse Agonist
    Schnute, Mark E.
    Wennerstal, Mattias
    Alley, Jennifer
    Bengtsson, Martin
    Blinn, James R.
    Bolten, Charles W.
    Braden, Timothy
    Bonn, Tomas
    Carlsson, Bo
    Caspers, Nicole
    Chen, Ming
    Choi, Chulho
    Collis, Leon P.
    Crouse, Kimberly
    Farnegardh, Mathias
    Fennell, Kimberly F.
    Fish, Susan
    Flick, Andrew C.
    Goos-Nilsson, Annika
    Gullberg, Hjalmar
    Harris, Peter K.
    Heasley, Steven E.
    Hegen, Martin
    Hromockyj, Alexander E.
    Hu, Xiao
    Husman, Bolette
    Janosik, Tomasz
    Jones, Peter
    Kaila, Neelu
    Kallin, Elisabet
    Kauppi, Bjorn
    Kiefer, James R.
    Knafels, John
    Koehler, Konrad
    Kruger, Lars
    Kurumbail, Ravi G.
    Kyne, Robert E., Jr.
    Li, Wei
    Lofstedt, Joakim
    Long, Scott A.
    Menard, Carol A.
    Mente, Scot
    Messing, Dean
    Meyers, Marvin J.
    Napierata, Lee
    Noteberg, Daniel
    Nuhant, Philippe
    Pelc, Matthew J.
    Prinsen, Michael J.
    Rhonnstad, Patrik
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (23) : 10415 - 10439
  • [42] NATURAL PRODUCT CHEMISTRY .168. ONE-POT SYNTHESIS OF 3-[2-(5,7,9-TRIMETHOXY-2,2-DIMETHYL-2H-PYRANO[2,3-B]QUINOLIN-4-YL)-3-HYDROXY-3-METHYL]BUTYL-4,6,8-TRIMETHOXY-1H-QUINOLIN-2-ONE
    REISCH, J
    NORDHAUS, P
    MONATSHEFTE FUR CHEMIE, 1993, 124 (11-12): : 1221 - 1224
  • [43] Discovery of N-[(4R)-6-(4-Chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist for the Treatment of Obesity
    Yan, Lin
    Huo, Pei
    Debenham, John S.
    Madsen-Duggan, Christina B.
    Lao, Julie
    Chen, Richard Z.
    Xiao, Jing Chen
    Shen, Chun-Pyn
    Stribling, D. Sloan
    Shearman, Lauren P.
    Strack, Alison M.
    Tsou, Nancy
    Ball, Richard G.
    Wang, Junying
    Tong, Xinchun
    Bateman, Thomas J.
    Reddy, Vijay B. G.
    Fong, Tung M.
    Hale, Jeffrey J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (10) : 4028 - 4037
  • [44] Optimization of Activity, Selectivity, and Liability Profiles in 5-0xopyrrolopyridine DPP4 Inhibitors Leading to Clinical Candidate (Sa)-2-(3-(Aminomethyl)-4-(2,4-dichloropheny1)-2-methyl5-oxo-5H-pyrrolo(3,4-b)pyridin-6(7H)-y1)-N,N-dimethylacetamide (BMS-767778)
    Devasthale, Pratik
    Wang, Ying
    Wang, Wei
    Fevig, John
    Feng, JianXin
    Wang, Aiying
    Harrity, Tom
    Egan, Don
    Morgan, Nathan
    Cap, Michael
    Fura, Aberra
    Klei, Herbert E.
    Kish, Kevin
    Weigelt, Carolyn
    Sun, Lucy
    Levesque, Paul
    Moulin, Frederic
    Li, Yi-Xin
    Zahler, Robert
    Kirby, Mark S.
    Hamann, Lawrence G.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (18) : 7343 - 7357